The evidence-based epidemiology of HCV-associated kidney disease

International Journal of Artificial Organs

Volumn 35, Issue 9, 2012, Pages 621-628

  Fabrizi, Fabrizio ^a,b   Dixit, Vivek ^b   Martin, Paul ^b   Messa, Piergiorgio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Hepatitis C virus (HCV); Proteinuria; Renal insufficiency

Indexed keywords

DISEASES; RANDOM PROCESSES; RISK ASSESSMENT; RISK PERCEPTION; VIRUSES;

CHRONIC KIDNEY DISEASE; EVIDENCE-BASED; HEPATITIS C VIRUS; INFORMATION SUPPORT; KIDNEY DISEASE; NOVEL INFORMATION; PROTEINURIA; RENAL INSUFFICIENCY; VIRUS INFECTION;

VIRUSES; RISK PERCEPTION;

CRYOGLOBULINEMIA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEPATITIS C; HUMANS; KIDNEY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84868036504     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139881203500901     Document Type: Review

References (55)

1. Kim WR. The burden of hepatitis C in the United States. Hepatology. 2002;36(5)(Suppl 1):S30-S34.
2. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13(17):2436-2441.
3. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993;328(7):465-470.
4. Fabrizi F, Pozzi C, Farina M, et al. Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal. Nephrol Dial Transplant. 1998; 13(8):1991-1997.
5. Charles ED, Dustin LB. Hepatitis C virus-induced cryoglobulinemia. Kidney Int. 2009;76(8):818-824.
6. Fabrizi F, Colucci P, Ponticelli C, Locatelli F. Kidney and liver involvement in cryoglobulinemia. Semin Nephrol. 2002; 22(4):309-318.
7. Cruzado JM, Carrera M, Torras J, Grinyó JM. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant. 2001;1(2):171-178.
8. Ozdemir BH, Ozdemir FN, Sezer S, Colak T, Haberal M. De novo glomerulonephritis in renal allografts with hepatitis C virus infection. Transplant Proc. 2006;38(2):492-495.
9. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kidney Dis. 2003;42(4):631-657.
10. Gopalani A, Ahuja TS. Prevalence of glomerulopathies in autopsies of patients infected with the hepatitis C virus. Am J Med Sci. 2001;322(2):57-60.
11. Arase Y, Ikeda K, Murashima N, et al. Glomerulonephritis in autopsy cases with hepatitis C virus infection. Intern Med. 1998;37(10):836-840.
12. El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 2002;36(6):1439-1445.
13. Kidney Disease: Improving Global Outcomes (KDIGO). Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int. 2008; (109):S1-S99.
14. McGuire BM, Julian BA, Bynon JS Jr, et al. Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med. 2006;144(10):735-741.
15. Jadoul M, Poignet JL, Geddes C, et al; HCV Collaborative Group. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant. 2004;19(4):904-909.
16. Bergman S, Accortt N, Turner A, Glaze J. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis. 2005; 45(4): 684-689.
17. Butt AA, Wang X, Fried LF. HCV infection and the incidence of CKD. Am J Kidney Dis. 2011;57(3):396-402.
18. Lee JJ, Lin MY, Yang YH, Lu SN, Chen HC, Hwang SJ. Association of hepatitis C and B virus infection with chronic kidney disease in an endemic area in Taiwan: A cross-sectional study. Am J Kidney Dis. 2010;56(1):23-31.
19. Dalrymple LS, Koepsell T, Sampson J, et al. Hepatitis C virus infection and the prevalence of renal insufficiency. Clin J Am Soc Nephrol. 2007;2(4):715-721.
20. Tsui JI, Vittinghoff E, Shlipak MG, et al. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med. 2007; 167(12):1271-1276.
21. Crook ED, Penumalee S, Gavini B, Filippova K. Hepatitis C is a predictor of poorer renal survival in diabetic patients. Diabetes Care. 2005;28(9):2187-2191.
22. Soma J, Saito T, Taguma Y, et al. High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. J Am Soc Nephrol. 2000;11(4):690-699.
23. Tsui JI, Vittinghoff E, Shlipak MG, O'Hare AM. Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 2006;17(4):1168-1174.
24. Moe SM, Pampalone AJ, Ofner S, Rosenman M, Teal E, Hui SL. Association of hepatitis C virus infection with prevalence and development of kidney disease. Am J Kidney Dis. 2008;51(6):885-892.
25. Asrani SK, Buchanan P, Pinsky B, Rey LR, Schnitzler M, Kanwal F. Lack of association between hepatitis C infection and chronic kidney disease. Clin Gastroenterol Hepatol. 2010;8(1):79-84.
26. Liangpunsakul S, Chalasani N. Relationship between hepatitis C and microalbuminuria: results from the NHANES III. Kidney Int. 2005;67(1):285-290.
27. Huang JF, Chuang WL, Dai CY, et al. Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link? J Intern Med. 2006;260(3):255-262.
28. Fabrizi F, Martin P, Dixit V, Messa P. HCV infection and chronic kidney disease in the general population: Meta-analysis of observational studies. Clin J Am Soc Nephrol 2012;7(4): 549-557.
29. Noureddine LA, Usman SA, Yu Z, Moorthi RN, Moe SM. Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis. Am J Nephrol. 2010;32(4):311-316.
30. Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology. 1997;25(5):1237-1244.
31. Sansonno D, Lauletta G, Montrone M, Grandaliano G, Schena FP, Dammacco F. Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol. 2005;140(3):498-506.
32. Sandri AM, Elewa U, Poterucha JJ, Fervenza FC. Treatment of hepatitis C-mediated glomerular disease. Nephron Clin Pract. 2011;119(2):c121-c129, discussion c129-c130.
33. Björnsson E, Angulo P. Hepatitis C and steatosis. Arch Med Res. 2007;38(6):621-627.
34. Delgado-Borrego A, Casson D, Schoenfeld D, et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation. 2004;77(5):703-710.
35. Fabrizi F, Messa P, Martin P, Takkouche B. Hepatitis C virus infection and post-transplant diabetes mellitus among renal transplant patients: a meta-analysis. Int J Artif Organs. 2008; 31(8):675-682.
36. Freiberg MS, Cheng DM, Kraemer KL, Saitz R, Kuller LH, Samet JH. The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals. AIDS. 2007;21(2):193-197.
37. Fukui M, Kitagawa Y, Nakamura N, Yoshikawa T. Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. JAMA. 2003;289(10):1245-1246.
38. Ishizaka Y, Ishizaka N, Takahashi E, et al. Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J. 2003;67(1):26-30.
39. Satapathy S, Lingisetty C, Williams S. Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection. Hepatol Int. 2011 Jun 23. [Epub ahead of print]
40. Derbala M, Shebl FM, Rashid A, Amer A, Bener A. Microalbuminuria in hepatitis C-genotype 4: effect of pegylated interferon and ribavirin. World J Gastroenterol. 2010;16(10): 1226-1231.
41. Kasuno K, Ono T, Matsumori A, et al. Hepatitis C virus-associated tubulointerstitial injury. Am J Kidney Dis. 2003;41(4): 767-775.
42. Stehman-Breen C, Alpers CE, Couser WG, Willson R, Johnson RJ. Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol. 1995;44(3):141-147.
43. Stehman-Breen C, Alpers CE, Fleet WP, Johnson RJ. Focal segmental glomerular sclerosis among patients infected with hepatitis C virus. Nephron. 1999;81(1):37-40.
44. Baid S, Pascual M, Williams WW Jr, et al. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Neohrol. 1999:10(1):146-153.
45. Markowitz G, Cheng J, Colvin R, Trebbin WM, D'Agati VD. Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol. 1998; 9(12):2244-52.
46. Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand? Ann Rheum Dis. 2008; 67(3):283-287.
47. Barsoum RS. Hepatitis C virus: from entry to renal injury-facts and potentials. Nephrol Dial Transplant. 2007;22(7):1840-1848.
48. Wornle M, Schmid H, Banas B, et al. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol. 2006;168(2):370-385.
49. Waldman M, Marshall V, Whitby D, Kopp JB. Viruses and kidney disease: beyond HIV. Semin Nephrol. 2008;28(6):595-607.
50. Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis. 2000;30(Suppl 1):S77-S84.
51. Szczech LA, Gange SJ, van der Horst C, et al. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002;61(1):195-202.
52. Franceschini N, Napravnik S, Eron JJ Jr, Szczech LA, Finn WE Incidence and etiology of acute renal failure among ambulatory HIV-infected patients. Kidney Int. 2005;67(4):1526-1531.
53. Gardner LI, Holmberg SD, Williamson JM, et al; HIV Epidemiology Research Study Group. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr. 2003;32(2):203-209.
54. Tsui J, Vittinghoff E, Anastos K, et al. Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study. Am J Kidney Dis. 2009;54(1):43-50.
55. Fischer MJ, Wyatt CM, Gordon K, et al; VACS Project Team. Hepatitis C and the risk of kidney disease and mortality in veterans with HIV. J Acquir Immune Defic Syndr. 2010;53(2):222-226.